Xiang-cheng Li - Publications

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

Journal: Lancet (London, England)

Published: April 29, 2026

Safety and efficacy of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus: A single-arm, multicenter, prospective study.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: June 16, 2025

Ultrafine percutaneous transhepatic cholangioscopy for biliary biopsy among patients with suspected malignant biliary obstruction.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: May 26, 2025

Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: December 05, 2024

Preoperative clinical and contrasted-enhanced CT features to predict perineural invasion in gallbladder carcinoma: focus on clinical T3-4 stage.

Journal: Abdominal radiology (New York)

Published: October 31, 2024

Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 25, 2024

Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target.

Journal: Clinical and molecular hepatology

Published: October 09, 2024

Particular Chinese contributions to extracorporeal liver surgery.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: August 16, 2024

Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: June 22, 2024

Differentiation and immunosuppressive function of CD19+CD24hiCD27+ regulatory B cells are regulated through the miR-29a-3p/NFAT5 pathway.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: May 27, 2023

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.

Journal: Cancer medicine

Published: April 22, 2022

Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-κB pathway.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 19, 2022